Tech Company Financing Transactions
ArkeaBio Funding Round
ArkeaBio, operating out of Reno, received $26.5 million from Breakthrough Energy Ventures, Grantham Foundation and Overview.
Transaction Overview
Company Name
Announced On
5/9/2024
Transaction Type
Venture Equity
Amount
$26,500,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to advance the research, development and deployment of the vaccine, including large-scale field trials and engagement along the supply chain.
Company Information
Company Status
Private & Independent
Industry
AgTech
Mailing Address
Undisclosed
Reno, NV 89519
USA
Reno, NV 89519
USA
Phone
Undisclosed
Website
Email Address
Overview
ArkeaBio is using innovative vaccine technologies to create solutions to reduce the on-farm methane emissions responsible for 6% of global GHG emissions. ArkeaBio technology will be integrated into proven delivery systems and farming practices to safely reduce global methane emissions from multiple ruminant species across a variety of geographies and agronomic systems.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Colin South
Vice President
Matthew Dunn
Browse more venture capital transactions:
Prev: 5/9/2024: Cheetah Technologies venture capital transaction
Next: 5/9/2024: Arch Labs venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs